🇺🇸 MRK — Merck & Co., Inc.
Salud CompraPrecio actual
146,73 USD
Máx. histórico
156,45
73 días
Split 1048:1000 del 03/06/2021
Caída desde máximo
-6,21%
Rango 52 semanas
85,24 – 156,92
Variación hoy
-0,14%
Cierre anterior
146,94
Rango de hoy
142,80 – 147,48
Volumen hoy
7.462.267
Peor caída histórica
-68,62%
28/12/2000 → 09/03/2009
Recuperado en 1796 días
Volatilidad anualizada ⓘ
25,43%
- Nombre completo
- Merck & Co., Inc.
- Divisa
- USD
- Mercado
- NYSE
- Sector
- Salud
- Industria
- Drug Manufacturers - General
- Empleados
- 73.000
- PER ⓘ
- 148,21 (puede no estar actualizado)
- Dividend yield
- 2,31% (puede no estar actualizado)
- Precio objetivo analistas
- 161,53 USD (puede no estar actualizado)
- Primera cotización
- 02/01/1962
- Precio actualizado
- hace 1 día
Merck & Co., Inc. operates as a healthcare company worldwide. It offers human health pharmaceutical for various areas under the Keytruda, Keytruda Qlex, Welireg, Gardasil, ProQuad, M-M-R II, Varivax, Vaxneuvance, Capvaxive, RotaTeq, Pneumovax 23, Bridion, Prevymis, Dificid, Zerbaxa, Winrevair, Adempas/ Verquvo, Ohtuvayre, Lagevrio, Isentress/Isentress HD, Delstrigo, Pifeltro, Belsomra, Januvia, and Janumet brands. The company also provides veterinary pharmaceuticals, vaccines and health management solutions and services, such as livestock products under the Nuflor, Bovilis/Vista, Bovilis Cryptium, Banamine, Estrumate, Matrix, Resflor, Zuprevo, Revalor, Safe-Guard, M+Pac, Porcilis, Circumvent, Nobilis/Innovax, Paracox and Coccivac, Exzolt, Slice, Imvixa, Clynav, Aquavac/Norvax, Aquaflor, Flexolt brands; Allflex Livestock Intelligence solutions; and companion animal products under the Bravecto One-Month, Bravecto Injectable/Quantum, Bravecto TriUNO, Bravecto Plus, Sentinel Spectrum, Sentinel Flavor Tabs, Numelvi, Optimmune, Nobivac NXT, GilvetMab, Otomax, Mometamax, Mometamax Ultra, Posatex, Caninsulin/Vetsulin, Panacur, Safeguard, Regumate, Prestige, Scalibor/Exspot, Sure Petcare, and Home Again brands. It has development and commercialization agreement for three of Daiichi Sankyo's deruxtecan ADC candidates; AstraZeneca PLC to co-development and co-commercialize AstraZeneca's Lynparza products for multiple cancer types; licensed to develop, manufacture and commercialize LM-299, a novel investigational PD-1/VEGF bispecific antibody from LaNova; and collaboration agreement with Eisai Co., Ltd., Bayer AG, and Ridgeback Biotherapeutics LP, as well Moderna, Inc. Merck & Co., Inc. has strategic collaboration with Infinimmune, Inc. to discover and develop antibodies against multiple therapeutic targets. The company was founded in 1891 and is headquartered in Rahway, New Jersey.
| Fecha de pago | Importe por participación |
|---|---|
| 15/09/2026 | 0,8500 USD |
| 15/06/2026 | 0,8500 USD |
| 16/03/2026 | 0,8500 USD |
| 15/12/2025 | 0,8500 USD |
| 15/09/2025 | 0,8100 USD |
| 16/06/2025 | 0,8100 USD |
| 17/03/2025 | 0,8100 USD |
| 16/12/2024 | 0,8100 USD |
| 16/09/2024 | 0,7700 USD |
| 17/06/2024 | 0,7700 USD |
| 14/03/2024 | 0,7700 USD |
| 14/12/2023 | 0,7700 USD |
| 14/09/2023 | 0,7300 USD |
| 14/06/2023 | 0,7300 USD |
| 14/03/2023 | 0,7300 USD |
| Fecha | Ratio |
|---|---|
| 03/06/2021 | 1048:1000 |
| 17/02/1999 | 2:1 |
| 26/05/1992 | 3:1 |
| 26/05/1988 | 3:1 |
| 27/05/1986 | 2:1 |
| 01/06/1972 | 2:1 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 13/10/1994 | 17,65 | 17,77 | 17,41 | 17,47 | -1,01% | 2,03% | 5.682.256 |
| 12/10/1994 | 17,29 | 17,65 | 17,24 | 17,65 | +1,37% | 2,41% | 5.683.514 |
| 11/10/1994 | 17,18 | 17,59 | 17,18 | 17,41 | +1,39% | 2,43% | 6.590.243 |
| 10/10/1994 | 17,24 | 17,24 | 17,06 | 17,18 | -0,35% | 1,04% | 2.437.858 |
| 07/10/1994 | 17,00 | 17,24 | 17,00 | 17,24 | +1,05% | 1,40% | 3.566.973 |
| 06/10/1994 | 17,00 | 17,12 | 16,94 | 17,06 | -0,69% | 1,05% | 4.526.731 |
| 05/10/1994 | 17,18 | 17,24 | 17,00 | 17,18 | -1,03% | 1,39% | 7.269.976 |
| 04/10/1994 | 17,41 | 17,65 | 17,29 | 17,35 | -0,34% | 2,06% | 10.207.939 |
| 03/10/1994 | 17,06 | 17,41 | 17,06 | 17,41 | +2,46% | 2,10% | 7.664.234 |
| 30/09/1994 | 16,88 | 17,18 | 16,82 | 17,00 | +1,06% | 2,12% | 5.308.120 |
| 29/09/1994 | 17,00 | 17,06 | 16,70 | 16,82 | -1,05% | 2,11% | 4.347.523 |
| 28/09/1994 | 16,94 | 17,24 | 16,94 | 17,00 | -1,04% | 1,76% | 10.898.990 |
| 27/09/1994 | 16,64 | 17,18 | 16,58 | 17,18 | +3,23% | 3,58% | 10.336.424 |
| 26/09/1994 | 16,40 | 16,76 | 16,40 | 16,64 | +0,72% | 2,18% | 5.542.453 |
| 23/09/1994 | 16,40 | 16,52 | 16,28 | 16,52 | +0,73% | 1,45% | 3.430.314 |
| 22/09/1994 | 16,58 | 16,58 | 16,40 | 16,40 | -0,72% | 1,08% | 3.772.171 |
| 21/09/1994 | 16,34 | 16,58 | 16,28 | 16,52 | +0,73% | 1,82% | 6.769.242 |
| 20/09/1994 | 16,40 | 16,52 | 16,28 | 16,40 | -0,72% | 1,45% | 4.696.298 |
| 19/09/1994 | 16,34 | 16,64 | 16,34 | 16,52 | +1,47% | 1,82% | 5.283.806 |
| 16/09/1994 | 16,16 | 16,40 | 16,10 | 16,28 | -0,36% | 1,85% | 9.550.843 |
| 15/09/1994 | 16,10 | 16,34 | 16,04 | 16,34 | +1,48% | 1,85% | 4.915.539 |
| 14/09/1994 | 15,98 | 16,10 | 15,98 | 16,10 | +0,37% | 0,75% | 3.212.749 |
| 13/09/1994 | 16,04 | 16,10 | 15,86 | 16,04 | +0,00% | 1,49% | 3.524.843 |
| 12/09/1994 | 15,98 | 16,10 | 15,98 | 16,04 | +0,00% | 0,75% | 2.856.010 |
| 09/09/1994 | 16,10 | 16,22 | 15,92 | 16,04 | -1,10% | 1,85% | 4.276.888 |
| 08/09/1994 | 16,22 | 16,28 | 16,16 | 16,22 | +0,00% | 0,74% | 4.151.338 |
| 07/09/1994 | 16,40 | 16,46 | 16,10 | 16,22 | +0,00% | 2,18% | 7.082.384 |
| 06/09/1994 | 16,16 | 16,22 | 16,04 | 16,22 | +0,37% | 1,11% | 3.379.171 |
| 02/09/1994 | 16,34 | 16,40 | 16,10 | 16,16 | -1,45% | 1,82% | 3.491.307 |
| 01/09/1994 | 16,28 | 16,52 | 16,22 | 16,40 | +0,73% | 1,83% | 5.568.234 |